MIM
MANE

MetLife Investment Management’s Veradermics Inc MANE Stock Holding History

MetLife Investment Management’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
+12,740
New +$1.19M 0.01% 1290

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MetLife Investment Management's MANE Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Veradermics Inc (MANE) in Q2 2026: 12,740 shares worth $1.57M. The stake represents 0.01% of the portfolio and ranks #1290 among its holdings.

148 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • MetLife Investment Management held 12,740 shares of Veradermics Inc worth $1.57M as of Q2 2026.
  • Veradermics Inc was a new MetLife Investment Management position in Q2 2026.
  • Veradermics Inc made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1290 holding.
  • 148 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.